Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc A Rodwin

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
International Journal of Health Services : Planning, Administration, Evaluation|February 1, 2020
Pharmaceutical Price and Spending Controls in France: Lessons for the United StatesMarc A Rodwin
American Journal of Law & Medicine|February 10, 2011
Patient data: property, privacy & the public interestMarc A Rodwin
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|November 17, 2011
Reforming pharmaceutical industry-physician financial relationships: lessons from the United States, France, and JapanMarc A Rodwin
BMJ (Clinical Research Ed.)|June 5, 2004
Financial incentives for doctorsMarc A Rodwin
Food and Drug Law Journal|December 4, 2015
Do We Need Stronger Sanctions to Ensure Legal Compliance By Pharmaceutical Firms?Marc A Rodwin
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|April 21, 2025
Negotiating Medicare Drug Prices: A New Attempt to Control Purchase PricesMarc A Rodwin
International Journal of Health Services : Planning, Administration, Evaluation|October 24, 2022
The No Surprises Act: A Conservative Band-Aid to Protect Business as UsualMarc A Rodwin, Alan Sager
International Journal of Health Services : Planning, Administration, Evaluation|October 20, 2021
German Pharmaceutical Pricing: Lessons for the United StatesMarc A Rodwin, Sara Gerke
JAMA|September 6, 2012
Clinical trial data as a public goodMarc A Rodwin, John D Abramson
Health Matrix (Cleveland, Ohio : 1991)|February 28, 2018
Why the Medical Malpractice Crisis Persists Even When Malpractice Insurance Premiums FallMarc A Rodwin, Justin Silverman, David Merfeld
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
International Journal of Health Services : Planning, Administration, Evaluation|February 1, 2020
Pharmaceutical Price and Spending Controls in France: Lessons for the United StatesMarc A Rodwin
American Journal of Law & Medicine|February 10, 2011
Patient data: property, privacy & the public interestMarc A Rodwin
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|November 17, 2011
Reforming pharmaceutical industry-physician financial relationships: lessons from the United States, France, and JapanMarc A Rodwin
BMJ (Clinical Research Ed.)|June 5, 2004
Financial incentives for doctorsMarc A Rodwin
Food and Drug Law Journal|December 4, 2015
Do We Need Stronger Sanctions to Ensure Legal Compliance By Pharmaceutical Firms?Marc A Rodwin
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|April 21, 2025
Negotiating Medicare Drug Prices: A New Attempt to Control Purchase PricesMarc A Rodwin
International Journal of Health Services : Planning, Administration, Evaluation|October 24, 2022
The No Surprises Act: A Conservative Band-Aid to Protect Business as UsualMarc A Rodwin, Alan Sager
International Journal of Health Services : Planning, Administration, Evaluation|October 20, 2021
German Pharmaceutical Pricing: Lessons for the United StatesMarc A Rodwin, Sara Gerke
JAMA|September 6, 2012
Clinical trial data as a public goodMarc A Rodwin, John D Abramson
Health Matrix (Cleveland, Ohio : 1991)|February 28, 2018
Why the Medical Malpractice Crisis Persists Even When Malpractice Insurance Premiums FallMarc A Rodwin, Justin Silverman, David Merfeld
Pageof 4